![LianBio logo](/logos/LIAN.webp)
LianBio
NASDAQ:LIAN
Overview | Financials
Company Name | LianBio |
Symbol | LIAN |
Currency | USD |
Price | 0.319 |
Market Cap | 34,472,097 |
Dividend Yield | 2,993.73% |
52-week-range | 0.241 - 4.99 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Yizhe Wang Ph.D. |
Website | https://www.lianbio.com |
An error occurred while fetching data.
About LianBio
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD